This company has been marked as potentially delisted and may not be actively trading. NYSE:NPD (NPD) (NPD) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (NPD) Stock (NYSE:NPD) 30 days 90 days 365 days Advanced Chart Get (NPD) alerts:Sign Up Key Stats Today's Range$2.55▼$2.5550-Day Range N/A52-Week Range$2.00▼$2.59VolumeN/AAverage Volume61,544 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview China Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items. The Company operates through the retail drugstore business segment. The Company also offers private label products. It has a network of approximately 1,990 directly operated drugstores spanning over 70 cities across approximately 14 provinces and direct-controlled municipalities in China. The Company offers approximately 2,170 private label products. The Company also operates an Internet Website, www.star365.com. It offers approximately 3,210 prescription drugs. It offers approximately 3,360 over-the-counter drugs, including western medicines and traditional Chinese medicines, for the treatment of common diseases. Read More Receive NPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NPD) and its competitors with MarketBeat's FREE daily newsletter. Email Address NPD Stock News HeadlinesMore than 1,600 pictures of child pornography found at Bay Area man’s home: PDJuly 19 at 4:28 AM | yahoo.comThree arrested for shooting that killed 1, injured 5 in NatchitochesJuly 18 at 9:44 PM | yahoo.comYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual SubscriptionJuly 19 at 2:00 AM | MarketBeat (Ad)Natchitoches police provide update on Keyser Ave homicide from July 6July 18 at 9:44 PM | msn.comNPD: 17-year-old boy shot and killed on West 35th StreetJuly 18 at 4:44 PM | msn.comWoman sets Novato church on fire in hate crime incident: NPDJuly 14, 2025 | msn.comNPD: Man arrested in fatal Bagnall Road shootingJuly 12, 2025 | yahoo.comNPD: Woman dies following shooting on Bagnall Road; suspect arrestedJuly 11, 2025 | msn.comSee More Headlines NPD Stock Analysis - Frequently Asked Questions How were (NPD)'s earnings last quarter? (NPD) (NYSE:NPD) posted its quarterly earnings results on Wednesday, November, 25th. The company reported $0.00 earnings per share for the quarter. The business earned $124.77 million during the quarter. What other stocks do shareholders of (NPD) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (NPD) investors own include Inovio Pharmaceuticals (INO), Avid Bioservices (CDMO), Corcept Therapeutics (CORT), Cardiome Pharma (CRME), CTI BioPharma (CTIC) and Sprott Focus Trust (FUND). Company Calendar Last Earnings11/25/2015Today7/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:NPD CIK1414850 WebN/A Phone+86-755-26435319FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:NPD) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NPD) Please log in to your account or sign up in order to add this asset to your watchlist. Share (NPD) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.